SCHEMBL24255914

SCHEMBL24255914

c1ccc(-c2ccc(N(c3ccc(-c4ccc5c(c4)oc4ccccc45)cc3)c3ccc4c(c3)C(c3ccccc3)(c3ccccc3)c3ccccc3-4)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.35
MMP13 P45452 1/20 0.35
PDK2 Q15119 1/20 0.33
AHR P35869 2/20 0.33
PLA2G2A P14555 2/20 0.32
PLA2G4A P47712 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
MAPT P10636 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
HCRTR1 O43613 1/20 0.32
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
ATM Q13315 1/20 0.31
LMNA P02545 1/20 0.31
OPRK1 P41145 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
ALOX5 P09917 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17735311 0.98 MMP12 (0.34) MMP12MMP13PDK2AHRPLA2G2A
SCHEMBL21558973 0.98 MMP12 (0.34) MMP12MMP13PDK2AHRPLA2G2A
SCHEMBL9916352 0.98 MMP12 (0.35) MMP12MMP13PDK2AHRPLA2G2A
SCHEMBL24923304 0.98 MMP12 (0.35) MMP12MMP13PDK2AHRPLA2G2A
SCHEMBL24255765 0.97 AHR (0.33) MMP12MMP13PDK2AHRPLA2G2A
SCHEMBL22151192 0.96 MMP12 (0.34) MMP12MMP13PDK2AHRPLA2G2A
SCHEMBL17790268 0.96 PDK2 (0.36) MMP12MMP13PDK2AHRPLA2G2A
SCHEMBL22150231 0.96 MEN1 (0.33) MMP12MMP13PDK2AHRPLA2G2A
SCHEMBL19448995 0.96 PDK2 (0.34) MMP12MMP13PDK2KDM4EMEN1
SCHEMBL21559326 0.95 AHR (0.32) MMP12MMP13PDK2AHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237513-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC APPLIANCE IDEMITSU KOSAN CO., LTD. (JP) 2024-07-11 US disclosed
US-20230337529-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2023-10-19 US disclosed
US-20230337529-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2023-10-19 US disclosed
WO-2022035097-A1 ORGANIC LIGHT-EMITTING DEVICE AND COMPOSITION FOR FORMING ORGANIC MATERIAL LAYER 엘티소재주식회사 2022-02-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240237513-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC APPLIANCE EED, PIEZO1, OLA1 MMP12 1208/4885MMP13 3162/4885PDK2 3110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.